All articles tagged: Asymptomatic human immunodeficiency virus [HIV] infection status (Z21)
![]()
Evalytics
01 April at 06.25 PM
HIV Remission in Children: A Hopeful DevelopmentHIV remission in children, characterized by a sustained period of undetectable viral load without the need for antiretroviral therapy (ART), represents a significant breakthrough in pediatric HIV care. This phenomenon, observed in children who have undergone a pause in treatment, offers new insights into the management and potential cure of HIV/AIDS. |
![]()
Evalytics
01 April at 06.07 PM
CDC alerts doctors to watch for rare, serious bacterial infection appearing with unusual symptomsCDC alerts rising cases of rare, deadly meningococcal infections in middle-aged adults, caused by ST-1466 strain with atypical symptoms and higher mortality rate. Transmission via respiratory secretions, symptoms include fever, chills, rapid deterioration; urgent antibiotic treatment and vaccination recommended. |
![]()
Evalytics
11 March at 01.28 AM
After decades of failures, researchers have renewed hopes for an effective HIV vaccineResearchers are optimistic about developing an effective HIV vaccine after decades of setbacks. Recent advancements in understanding immune responses offer renewed hope. New vaccine candidates are showing promising results in early trials, sparking optimism for future HIV prevention strategies. |
![]()
Evalytics
11 March at 01.26 AM
HIV Remission in Children: A Hopeful DevelopmentPediatric HIV remission, marked by prolonged undetectable viral load sans antiretroviral therapy (ART), is a notable advance. This condition, seen in children with treatment pauses, offers fresh perspectives on HIV/AIDS management and potential cure. |
![]()
Evalytics
05 February at 08.29 PM
Scientists see an ultra-fast movement on surface of HIV virusDuke researchers have identified a key moment in HIV infection, where the virus's envelope glycoprotein opens to attach to T-cells. This discovery offers new directions for AIDS vaccine development, focusing on antibodies that block this process, and marks a significant shift in understanding HIV's infection mechanism. |
![]()
HealthDay
22 January at 04.48 PM
Risk Factor Control May Modify Link Between HIV Status and Heart DiseaseControl of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.Michael J. Silverberg, Ph.D., M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues conducted a retrosp |
![]()
HealthDay
08 January at 11.43 PM
Increase in Out-of-Pocket Costs Could Increase Abandonment of HIV PrEP MedsAn increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to a study published in the January issue of Health Affairs.Lorraine T. Dean, Sc.D., from Johns Hopkins University in Baltimore, and colleagues estimated the risk-adj |
![]()
HealthDay
08 January at 11.43 PM
Increase in Out-of-Pocket Costs Could Increase Abandonment of HIV PrEP MedsAn increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to a study published in the January issue of Health Affairs.Lorraine T. Dean, Sc.D., from Johns Hopkins University in Baltimore, and colleagues estimated the risk-adj |
![]()
HealthDay
05 January at 10.20 PM
FDA Allows Florida to Import Cheaper Drugs From CanadaIn what could prove to be a major turning point for the prescription drug market in the United States, the U.S. Food and Drug Administration has approved a Florida plan to import drugs from Canada.U.S. residents can now buy directly from Canadian pharmacies out of their own pockets, but state Medicaid programs have not been allowed to purcha |
![]()
HealthDay
21 December at 04.13 PM
Doxycycline Postexposure Prophylaxis Does Not Avert STIs in WomenFor Kenyan women receiving preexposure prophylaxis against HIV, the incidence of sexually transmitted infections (STIs) does not differ for those receiving doxycycline postexposure prophylaxis (PEP) compared with standard care, according to a study published in the Dec. 21 issue of the New England Journal of Medicine.Jenell Stewart, D |
![]()
HealthDay
18 December at 10.29 PM
2014 to 2021 Saw Increase in HIV Testing, PrEP in Transgender PersonsFrom 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published online Dec. 19 in the Annals of Internal Medicine.Ya-Lin A. Huang, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estim |
![]()
HealthDay
12 December at 04.09 PM
Virological Suppression Sustained With Very Early ART in Neonates With HIV-1For neonates with in utero HIV-1, very early antiretroviral therapy (ART) can achieve sustained virological suppression, according to a study published online Dec. 4 in The Lancet HIV.Deborah Persaud, M.D., from Johns Hopkins University School of Medicine in Baltimore, and colleagues enrolled infants at 30 research clinics in 11 countr |
![]()
HealthDay
30 November at 10.02 PM
Mortality Increased for Infants, Under 5s With HIV Receiving AntiretroviralsMore infants and children aged younger than 5 years with HIV receiving antiretroviral therapy (ART) die compared with those aged 5 years and older receiving ART, according to research published in the Dec. 1 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Nickolas T. Agathis, M.D., fr |
![]()
HealthDay
28 November at 04.36 PM
Two-Week DAA Prophylaxis Prevents Hep C After Kidney TransplantTwo-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according to a study published online Nov. 28 in the Annals of Internal Medicine.Niraj M. Desai, M.D., from the Johns Hopkins Univ |
![]()
Evalytics
20 November at 06.23 PM
Nearly 450 patients at Massachusetts hospital may have been exposed to HIV, hepatitisChatGPT Nearly 450 patients at Salem Hospital in Massachusetts may have been exposed to hepatitis B, C, and HIV due to improper practices during endoscopy procedures over two years. The hospital corrected the issue, notified affected patients, and offered free screenings. The risk of infection is considered very low, with no reported infections from this incident. Salem Hospital and its parent com |
![]()
HealthDay
16 November at 09.53 PM
First OTC Test for Chlamydia, Gonorrhea Approved by the FDAOn Wednesday, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple 2 Test, the first home test for chlamydia and gonorrhea.People will be able to buy the Simple 2 Test over-the-counter at a pharmacy, take a specimen at home, and send their sample to a designated laboratory for testing, the FDA |
![]()
HealthDay
03 November at 03.36 PM
One in Four Young Sexual-, Gender-Minority Individuals May Experience SyphilisOne-quarter of young sexual and gender minorities (YSGM) have syphilis at some point in their lives, according to a study published online Oct. 10 in the Journal of Infectious Diseases.Casey D. Xavier Hall, M.P.H., Ph.D., from Florida State University in Tallahassee, and colleagues examined syphilis incidence and prevalence prospect |
![]()
HealthDay
30 October at 04.07 PM
2018 to 2021 Saw Increase in HIV PrEP Provision for AdolescentsFrom 2018 to 2021, there was an increase in HIV preexposure prophylaxis (PrEP) provision among adolescents, especially among male and older adolescents, according to a study published online Oct. 30 in Pediatrics.Anne A. Kimball, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined t |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |